1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Vaccines Market Size Growth Rate by Type (2022-2028)
1.2.2 Being Developed
1.2.3 Preclinical
1.2.4 Clinical I
1.2.5 Clinical II
1.3 Market by Application
1.3.1 Global mRNA Vaccines Market Share by Application (2022-2028)
1.3.2 COVID-19
1.3.3 Cancer
1.3.4 Infectious Disease Treatment MRNA Vaccine
1.3.5 Infection Prevention MRNA Vaccine
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global mRNA Vaccines Market Size
2.2 mRNA Vaccines Market Size by Regions
2.2.1 mRNA Vaccines Growth Rate by Regions (2022-2028)
2.2.2 mRNA Vaccines Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 mRNA Vaccines Revenue by Players (2022 & 2028)
3.2 mRNA Vaccines Key Players Headquarters and Area Served
3.3 Key Players mRNA Vaccines Product/Solution/Service
3.4 Date of Enter into mRNA Vaccines Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global mRNA Vaccines Market Size by Type (2022-2028)
4.2 Global mRNA Vaccines Market Size by Application (2022-2028)
5 North America
5.1 North America mRNA Vaccines Market Forecast (2022-2028)
5.2 mRNA Vaccines Key Players in North America
5.3 North America mRNA Vaccines Market Size by Type
5.4 North America mRNA Vaccines Market Size by Application
6 Europe
6.1 Europe mRNA Vaccines Market Forecast (2022-2028)
6.2 mRNA Vaccines Key Players in Europe
6.3 Europe mRNA Vaccines Market Size by Type
6.4 Europe mRNA Vaccines Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific mRNA Vaccines Market Forecast (2022-2028)
7.2 mRNA Vaccines Key Players in Asia-Pacific
7.3 Asia-Pacific mRNA Vaccines Market Size by Type
7.4 Asia-Pacific mRNA Vaccines Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America mRNA Vaccines Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa mRNA Vaccines Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Player Profiles
9.1 MODERNA
9.1.1 MODERNA Company Details
9.1.2 MODERNA Description and Business Overview
9.1.3 MODERNA mRNA Vaccines Introduction
9.1.4 MODERNA Revenue in mRNA Vaccines Business (2022 & 2028)
9.1.5 MODERNA Recent Development
9.2 Pfizer
9.2.1 Pfizer Company Details
9.2.2 Pfizer Description and Business Overview
9.2.3 Pfizer mRNA Vaccines Introduction
9.2.4 Pfizer Revenue in mRNA Vaccines Business (2022 & 2028)
9.2.5 Pfizer Recent Development
9.3 Zydus Cadila
9.3.1 Zydus Cadila Company Details
9.3.2 Zydus Cadila Description and Business Overview
9.3.3 Zydus Cadila mRNA Vaccines Introduction
9.3.4 Zydus Cadila Revenue in mRNA Vaccines Business (2022 & 2028)
9.3.5 Zydus Cadila Recent Development
9.4 Fosun Pharmaceutical
9.4.1 Fosun Pharmaceutical Company Details
9.4.2 Fosun Pharmaceutical Description and Business Overview
9.4.3 Fosun Pharmaceutical mRNA Vaccines Introduction
9.4.4 Fosun Pharmaceutical Revenue in mRNA Vaccines Business (2022 & 2028)
9.4.5 Fosun Pharmaceutical Recent Development
9.5 CureVac
9.5.1 CureVac Company Details
9.5.2 CureVac Description and Business Overview
9.5.3 CureVac mRNA Vaccines Introduction
9.5.4 CureVac Revenue in mRNA Vaccines Business (2022 & 2028)
9.5.5 CureVac Recent Development
9.6 Stemirna
9.6.1 Stemirna Company Details
9.6.2 Stemirna Description and Business Overview
9.6.3 Stemirna mRNA Vaccines Introduction
9.6.4 Stemirna Revenue in mRNA Vaccines Business (2022 & 2028)
9.6.5 Stemirna Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
